ICG's Head of Economic and Investment Research Nicholas Brooks joined Haidi Stroud-Watts and Paul Allen on Bloomberg News Daybreak: Australia to discuss Fed rate cuts, US equity valuations and the prospect of outperformance in Asia and Europe. Capital at risk.

ICG’s European Mid-Market team is delighted to announce its partnership with leading UK travel insurance specialist, Staysure Group.
🔗Read more: icgam.com/2024/04/08/icg…

🔗Explore ICG European Mid-Market: icgam.com/what-we-do/cor…

#PrivateCapital #PrivateMarkets
Capital at risk.

The ICG European Infrastructure team has entered exclusive negotiations to sell Groupe Ocea to EQT Group. The transaction is subject to customary regulatory conditions and approvals, and is expected to close in Q2-Q3 2024. Capital at risk.
icgam.com/2024/04/04/the…

$1bn final close for ICG’s debut LP Secondaries fund.

LP Secondaries is dedicated to acquiring quality buyout funds, with exclusive focus on transacting limited partner-led deals.

🔗 icgam.com/2024/04/02/icg…

Capital at risk.

#Secondaries #PrivateEquity #PrivateMarkets

ICG Life Sciences-backed Amolyt Pharma will be acquired by AstraZeneca for up to $1.05bn in total consideration. The transaction is expected to close in Q3 2024, subject to agreement conditions and regulatory approvals. Capital at risk.*

🔗 Press release:…

Watch the highlights from our International Women’s Day networking breakfast with Vanessa Vallely OBE, CEO and Founder of WeAreTheCity🌟

#IWD2024 #Diversity #Inclusion #Equality #DEI #EmbraceEquity #PrivateMarkets #PrivateEquity #AssetManagement

This #IWD , ICG celebrated with a networking breakfast featuring keynote speaker, Vanessa Vallely OBE. Packed full of insights and actions for all genders, Vanessa’s ‘power of profile’ talk tackled multiple topics including impostor syndrome, brand-building, and networking.

#IWD 2024 #DEI

Congratulations to ICG and Schroders who were announced as winners of the LIFTS process today 👏 This brings forward one element to expanding the UK’s position as a hub for #privatecapital and making the UK one of the best places to scale and grow a business.

ICG plc has been awarded £100 million by the British Business Bank to invest into the UK’s most innovative life sciences companies which will also be matched by Phoenix Group.

Read more: bit.ly/3wH84yN

📣 Announced in today’s #Budget2024 :

The British Business Bank will award £250m under the Long-Term Investment for Technology and Science (LIFTS) initiative to create two investment vehicles to support UK innovative companies.

Read more: bit.ly/3wH84yN

🪙 The British Business Bank is to provide £100m into the ICG Life Sciences strategy
🪙 Phoenix Group also joins as co-anchor with a £100m commitment
🔗 icgam.com/2024/03/06/icg…
Capital at risk.
British Business Bank Phoenix Group | #LifeSciences #Healthcare #Pensions #PrivateMarkets

“At ICG Strategic Equity we continue to push the quantum of capital that can be transacted with a sole buyer, pursuing continuation vehicle sizes up to $1.5 billion.”
🔗 Read in full: icgam.com/2024/03/04/the…
Capital at risk.
#Secondaries #Alternatives

ICG’s DEI performance has been ranked #1 in the 2024 Honordex Index, for a second consecutive year. Equality Group’s methodology utilises reliably-sourced and expertly-analysed data, and we are immensely proud to be recognised by this leading industry #DEI benchmark.

ICG Real Estate is a top performer within Europe, winning 3 categories across Real Estate Capital & PERE 2023 Awards. Congratulations to the ICGRE team!
🏆🔗 REC Europe: recapitalnews.com/rec-europe-awa…
🏆🔗 PERE: perenews.com/pere-awards-20…
#RealEstate #Alternatives
Capital at risk.

ICG is proud to be named ‘Junior Lender of the Year, Europe’ and ‘Junior Lender of the Year, Asia-Pacific‘ by PrivateDebtInvestor in its annual PDI Awards 2023.
🔗 privatedebtinvestor.com/pdi-annual-awa…
Capital at risk.
#PrivateCapital #PrivateMarkets #PrivateDebt #Alternatives #Alts #Awards

“The visibility of our growth is now clearer than it’s ever been,” said CFO David Bicarregui during last week’s shareholder seminar on our approach to ‘scale-out’.
🔗 Explore our platform: icgam.com/what-we-do/
Capital at risk.
#PrivateMarkets #PrivateCapital #Alternatives

ICG is delighted to announce that its Asia Pacific Corporate team has entered into a strategic partnership with day surgery operator, Alfa Medicus, building on its track record within the APAC healthcare sector 👨‍⚕️

#PrivateMarkets

Capital at risk.

Our Life Sciences team is pleased to be among the signatories of a BVCA-backed, UK agreement committing to increasing investment into private capital – the Venture Capital Investment Compact. Team Head Allan Marchington has joined its Pensions & Private Capital Expert Panel.

🔗…

Delighted to have been a part of SEO London's #AICON24 Conference, with Co-Head of Senior Debt Partners (SDP), Peter Lockhead, featuring on panel, ‘Private credit and direct lending trends’, and Head of Real Estate, Krysto Nikolic, facilitating the ‘Real assets – state of…